⌘K

Login Start Free

Home/Filings/4/0000950170-24-139062

4//SEC Filing

Henderson Molly 4

Accession 0000950170-24-139062

CIK 0001783183other

View on SEC.gov Company Profile

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:20 PM ET

Size

5.3 KB

Accession

0000950170-24-139062

Insider Transaction Report

Form 4

Period: 2024-12-19

Phathom Pharmaceuticals, Inc.PHAT

Henderson Molly

CFO and CBO

Transactions

Sale
Common Stock
2024-12-19$8.00/sh−1,291$10,328→ 98,156 total

Holdings

Common Stock
(indirect: By 401(k))
1,911.27

Footnotes (1)

[F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Phathom Pharmaceuticals, Inc.

CIK 0001783183

Entity typeother

Related Parties

1

filerCIK 0001363812

Filing Metadata

Form type: 4
Filed: Dec 19, 7:00 PM ET
Accepted: Dec 20, 4:20 PM ET
Size: 5.3 KB

View on SEC.gov